Biosynthesis; Chemistry; Mechanisms of Action and Resistance. Molecular Nature of a Streptomycin and Sulfonamide Resistance. Plasmid (pBP1) Prevalent in ...
Antimicrobial Agents and Cheniotherapy Volume 19
Contents for March 1981
Number 3
Biosynthesis; Chemistry; Mechanisms of Action and Resistance Molecular Nature of a Streptomycin and Sulfonamide Resistance Plasmid (pBP1) Prevalent in Clinical Escherichia coli Strains and Integration of an Ampicillin Resistance Transposon (TnA). ULRICH VAN TREECK, FREIDRICH SCHMIDT, AND BERND WIEDEMANN* ..................................... Differences Between Ceftizoxime and Its Stereoisomer in Antibacterial Activity and Affinity for Penicillin-Binding Proteins. YASUTAKA SHIGI, HITOSHI Kojo, MAMIKO WAKASUGI, AND MINORu NISHIDA* ............. .......................... Antibacterial Activity of 2',3'-Dideoxyadenosine In Vivo and In Vitro. GEORGE BESKID,* BARNET ESKIN, Roy CLEELAND, JOANN SIEBELIST, AUDREY J. CAPPETTA, ANITA D. HILL, AND ROBERT H. GEIGER ......................... Microbial Transformations of N-Methylcolchiceinamide. PATRICK J. DAVIS ................................................. Nifurzide, a Nitrofuran Antiinfectious Agent: Interaction with Escherichia coli Cells. ANNE DELSARTE, MICHEL FAWAY, JEANMARIE FRERE,* JACQUES COYETTE, CLAIRE-MICHELE CALBERG-BACQ, AND ERNST HEINEN ....... .................... Filament Formation of Fusobacterium nucleatum Cells Induced by Mecillinam. TAKATOSHI ONOE, ToSHIO UMEMOTO, HIROSUKE SAGAWA, AND HIDEKAZU SUGINAKA* ....................... Isolation and Identification of Gamma-Aminobutyric Acid in Streptomyces lincolnensis. WILLARD J. HAAK* AND LESTER M.
REINEKE ................................................
Physiological Effects and Microbial Susceptibility In Vitro Activity of Naftifine, a New Antifungal Agent. APOSTOLOS GEORGOPOULOS,* GABOR PETRANYI, HUBERT MIETH, AND JURGEN DREWS .............................................. ,8-Lactam Resistance in Serratia marcescens: Comparison of Action of Benzylpenicillin, Apalcillin, Cefazolin, and Ceftizoxime. NAOKi TAKATA, HIDEKAZU SUGINAKA,* SHozo KOTANI, MICHIO OGAWA, AND GORo KoSAKI ................................ In Vitro Activity of N-Formimidoyl Thienamycin in Comparison with Cefotaxime, Moxalactam, and Ceftazidime. LUDO VERBIST* AND JAN VERHAEGEN ......... ............ Comparison of In Vitro Activities of Eight f3-Lactamase-Stable Cephalosporins Against fi-Lactamase-Producing Gram-Negative Ba......................... cili. LUDO VERBIST ............ Antibacterial Activity of Ceftriaxone (Ro 13-9904), a ,B-LactamaseStable Cephalosporin. HAROLD C. NEU,* NEAL J. MEROPOL, AND KWUNG P. FU ............. .......................... Development and Validation of a Neutralizer System for In Vitro Evaluation of Some Antiseptics. WAHEED SHEIKH ...... .....
_
371-380
393-396 /
424-428-
465-469
477-486 487-489
493
386-389
397-401
402-406 407-413
414-423 429-434
Continued on following page
Continued from preceding page
Comparative In Vitro Studies of Ro 13-9904, a New Cephalosporin ........... Derivative. T. C. EICKHOFF* AND J. EHRET ..... In Vitro Comparison of Third-Generation Cephalosporins, Piperacillin, Dibekacin, and Other Aminoglycosides Against Aerobic Bacteria. LYNN PULLIAM,* W. KEITH HADLEY, AND JOHN MILLS Pharmacology and Therapeutics Prevention of Acute and Chronic Ascending Pyelonephritis in Rats by Aminoglycoside Antibiotics Accumulated and Persistent in
-435-442 490-492
381-385 Kidneys. JACQUES BILLE AND MICHEL P. GLAUSER* ... In Vivo Antimycotic Activity of Naftifine. GABOR PETRANYI, * 390-392 APOSTOLOS GEORGOPOULOS, AND HUBERT MIETH ........... Pharmacokinetics of Cefuroxime in Normal and Impaired Renal Function: Comparison of High-Pressure Liquid Chromatography and Microbiological Assays. ROBERT W. BUNDTZEN, ROGER D. TOOTHAKER, OLE S. NIELSEN, PAUL 0. MADSEN, PETER G. -443-449 WELLING, AND WILLIAM A. CRAIG* ........................ Piperacillin Pharmacokinetics in Subjects with Chronic Renal Failure. MARIETTA I. B. THOMPSON, MARY E. Russo,* JOHN M. 450-453 ....... MATSEN, AND ELISABET ATKIN-THOR ...... Antimicrobial Activity of Cefmenoxime (SCE-1365). JOHN M. STAMM,* ROLAND L. GIROLAMI, NATHAN L. SHIPKOWITZ, AND '454-460 ROBERT R. BOWER ....................................1... Pharmacokinetics of Moxalactam in Patients with Renal Insufficiency. MILDRED LAM, CARL V. MANION, AND ANTHONY W. ..... .....-.......461-464 ......... CZERWINSKI* .. Antiviral Activity of Win 41258-3, a Pyrazole Compound, Against Herpes Simplex Virus in Mouse Genital Infection and in Guinea Pig Skin Infection. F. PANCIC,* B. A. STEINBERG, G. D. DIANA, 470-476 P. M. CARABATEAS, W. G. GORMAN, AND P. E. CAME ........ * Asterisk refers to person to whom inquiries regarding the paper should be addressed.
